Relapse‐associated worsening in a real‐life multiple sclerosis cohort: the role of age and pyramidal phenotype

Background and purpose The overall disability in patients with relapsing–remitting multiple sclerosis is likely to be partly rather than entirely attributed to relapse. Materials and methods The aim was to investigate the determinants of recovery from first relapse and relapse‐associated worsening (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of neurology 2023-09, Vol.30 (9), p.2736-2744
Hauptverfasser: Zanghì, Aurora, Galgani, Simonetta, Bellantonio, Paolo, Zaffaroni, Mauro, Borriello, Giovanna, Inglese, Matilde, Romano, Silvia, Conte, Antonella, Patti, Francesco, Trojano, Maria, Avolio, Carlo, D'Amico, Emanuele
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and purpose The overall disability in patients with relapsing–remitting multiple sclerosis is likely to be partly rather than entirely attributed to relapse. Materials and methods The aim was to investigate the determinants of recovery from first relapse and relapse‐associated worsening (RAW) in relapsing–remitting multiple sclerosis patients from the Italian MS Registry during a 5‐year epoch from the beginning of first‐line disease‐modifying therapy. To determine recovery, the functional system (FS) score was used to calculate the difference between the score on the date of maximum improvement and the score before the onset of relapse. Incomplete recovery was defined as a combination of partial (1 point in one FS) and poor recovery (2 points in one FS or 1 point in two FSs or any other higher combination). RAW was indicated by a confirmed disability accumulation measured by the Expanded Disability Status Scale score confirmed 6 months after the first relapse. Results A total of 767 patients had at least one relapse within 5 years of therapy. Of these patients, 57.8% experienced incomplete recovery. Age (odds ratio [OR] 1.02, 95% confidence interval [CI] 1.01–1.04; p = 0.007) and pyramidal phenotype were associated with incomplete recovery (OR = 2.1, 95% CI 1.41–3.14; p 
ISSN:1351-5101
1468-1331
DOI:10.1111/ene.15910